CYP27A1 and breast carcinoma: Larger epidemiological studies evaluating tumor tissue samples have indirectly investigated the effect of 27-HC on breast cancer prognosis by quantifying the levels of protein or mRNA expression of the enzymes converting cholesterol to 27-HC (CYP27A1) or metabolizing 27-HC to downstream metabolites (CYP7B1).